Luc F. Van Gaal

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 3.9K citations

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Luc F. Van Gaal, Aila Rissanen, André Scheen et al. · The Lancet · 2005 · 1.5K citations · Full text

Obesity, Metabolic Syndrome, Cannabis Use +10

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

W. P. T. James, Ian D. Caterson, Walmir Coutinho et al. · New England Journal of Medicine · 2010 · 924 citations · Full text

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

W. P. T. James, Arne Astrup, Nick Finer et al. · The Lancet · 2000 · 817 citations

Obesity, Nutrition, Weight Loss +8

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

Robert J. Heine, Luc F. Van Gaal, Don Johns et al. · Annals of Internal Medicine · 2005 · 794 citations